ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
NCT05318027
Summary
Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks
Eligibility
Inclusion Criteria: * Adults (age \>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment. * Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly * Ability read and respond in English * Ability to provide informed consent to participate in the study Exclusion Criteria: * Patients who are bed bound at baseline (ECOG 4) * Patients who rely on a wheelchair for ambulation
Conditions4
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05318027